Listening to Bluetooth Beacons for Epidemic Risk Mitigation

The ongoing COVID-19 pandemic let to efforts to develop and deploy digital contact tracing systems to expedite contact tracing and risk notification. Unfortunately, the success of these systems has been limited, partly owing to poor interoperability with manual contact tracing, low adoption rates, and a societally sensitive trade-off between utility and privacy. In this work, we introduce a new privacy-preserving and inclusive system for epidemic risk assessment and notification that aims to address these limitations. Rather than capturing pairwise encounters between user devices as done by existing systems, our system captures encounters between user devices and beacons placed in strategic locations where infection clusters may originate. Epidemiological simulations using an agent-based model demonstrate that, by utilizing location and environmental information and interoperating with manual contact tracing, our system can increase the accuracy of contact tracing actions and may help reduce epidemic spread already at low adoption.

What guidance does HIPAA offer to providers considering familial risk notification and cascade genetic testing?

Background It is unclear how the Health Insurance Portability and Accountability Act (HIPAA) should be interpreted in the context of sharing of genomic information between family members. Methods The authors analyzed the HIPAA Privacy Rule, reviewed the literature and constructed a clinical scenario to inform how HIPAA can be interpreted for multiple forms of patient- and provider-mediated genetic risk notification. Results Under HIPAA, healthcare providers can lawfully notify relatives to recommend genetic risk assessment using multiple approaches, including supporting the patient telling their own relatives, contacting relatives directly with the patient’s authorization, or contacting a relative’s provider directly. Conclusions Multiple forms of patient- or provider-mediated contact of relatives are already legally permissible under HIPAA, are consistent with ethical obligations of care to patients and their families, and could result in improved population health through identification of clinically actionable disease risk. Unanswered questions remain about implementation and impacts of provider-mediated programs.

Open problems in traceability: from raw materials to finished food products

Even though the main EU regulations concerning food traceability have already entered to force since many years, we still remark very wide and impacting product recalls, which often involve simultaneously large territories and many countries. This is a clear sign that current traceability procedures and systems, when implemented with the only aim of respecting mandatory policies, are not effective, and that there are some aspects that are at present underestimated, and therefore should be attentively reconsidered. In particular, the sole adoption of the so-called “one step back-one step forward traceability” to comply the EC Regulation 178/2002, where every actor in the chain handles merely the data coming from his supplier and those sent to his client, is in fact not sufficient to control and to limit the impact of a recall action after a risk notification. Recent studies on lots dispersion and routing demonstrate that each stakeholder has to plan his activities (production, transformation or distribution) according to specific criteria that allow pre-emptively estimating and limiting the range action of a possible recall. Moreover, these new and very recently proposed techniques still present some limits; first of all the problem of traceability of bulk products (e.g. liquids, powders, grains, crystals) during production phases that involve mixing operations of several lots of different/same materials. In fact, current traceability practices are in most cases unable to deal efficiently with this kind of products, and, in order to compensate the lack of knowledge about lot composition, typically resort to the adoption of very large lots, based for instance on a considered production period. Aim of this paper is to present recent advances in the design of supply chain traceability systems, discussing problems that are still open and are nowadays subject of research.